Central mediation of the effects of interleukin-1 on social exploration and body weight in mice

Psychoneuroendocrinology

Volumn 22, Issue 1, 1997, Pages 1-11

  Bluthé, Rose Marie ^a   Dantzer, Robert ^a   Kelley, Keith W ^b  

^a INSERM   (France)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

body weight; interleukin 1; interleukin 1 receptor antagonist; mouse; receptor; social behavior

Indexed keywords

CYTOKINE;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR;

ANIMALS; BODY WEIGHT; BRAIN; ENERGY METABOLISM; EXPLORATORY BEHAVIOR; HUMANS; INTERLEUKIN-1; MALE; MICE; MICE, INBRED STRAINS; RECEPTORS, INTERLEUKIN-1; SOCIAL BEHAVIOR;

EID: 0030945324     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(96)00042-X     Document Type: Article

References (46)

1. Arend WP (1991) Interleukin-1 receptor antagonist: a new member of the interleukin-1 family. J Clin Invest 88:1445-1451.
2. Balavoine JF, de Rochemonteix B, Williamson K, Seckinger P, Cruchaud A, Dayer JM (1986) Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin-1 and inhibitor(s). J Clin Invest 78:1120-1124.
3. Bluthé RM, Beaudu C, Kelley KW, Dantzer R (1995) Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats. Brain Res 677:171-176.
4. Bluthé RM, Dantzer R, Kelley KW (1989) CRF is not involved in the behavioral effects of peripherally injected interleukin-1 in the rat. Neurosci Res Commun 5:149-154.
5. Bluthé RM, Michaud B, Kelley KW, Dantzer R (1996) Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. NeuroReport 7:1485-1488.
6. Bluthé RM, Parnet P, Dantzer R, Kelley KW (1991) Interleukin-1 receptor antagonist blocks effects of IL-1α and IL-1β on social behaviour and body weight in mice. Neurosci Res Commun 9:151-158.
7. Bluthé RM, Walter V, Parnet P, Layé S, Lestage J, Verrier D, Poole S, Stenning BE, Kelley KW, Dantzer R (1994) Lipopolysaccharide induce sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci 317:499-503.
8. Carter DB, Deibel MR Jr, Dunn CJ, Tomich CSC, Laborde AL, Slighton JL, Berger AE, Bienkowski MJ, Sun FF, McEwan RN, Harris PKW, Yem AW, Waszak GA, Chosay JG, Sieu LC, Hardee MM, Zurcher-Neely HA, Reardon IM, Heinrikson RL, Truedell SE, Shelley JA, Taylor BM, Tracey DE (1990) Purification, cloning, expression and biological activity of an interleukin-1 receptor antagonist protein. Nature 344:633-637.
9. Colotta F, Dower SK, Sims JE, Mantovani A (1994) The type II «decoy» receptor: a novel regulatory pathway for interleukin-1. Immunol Today 15:562-565.
10. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475.
11. Cunningham ET, Wada E, Carter DB, Tracey DE, Battey JF, De Souza EB (1992) In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary and adrenal gland of the mouse. J Neurosci 12:1101-1104.
12. Dantzer R, Bluthé RM, Kelley KW (1991) Androgen-dependent vasopressinergic neurotransmission attenuates interleukin-1-induced sickness behavior. Brain Res 537:115-120.
13. Dantzer R, Bluthé RM, Kent S, Goodall G (1993) Behavioral effects of cytokines: an insight into mechanisms of sickness behavior. In: De Souza EB (Ed), Neurobiology of Cytokines, Academic Press, Orlando, FL. pp. 130-150.
14. Dinarello C (1996) Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
15. Dinarello CA, Thompson RC (1991) Blocking IL-1: interleukin-1 I receptor antagonist in vivo and in vitro. Immunol Today 12:404-410.
16. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP (1991a) Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 266:10331-10336.
17. Dripps DJ, Verderber E, Ng RK, Thompson RC, Eisenberg SP (1991b) Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. J Biol Chem 266:20311-20315.
18. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346.
19. Gatti S, Bartfai T (1993) Induction of tumor necrosis factor-α mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res 624:291-294.
20. Granowitz EV, Clark BD, Mancilla J, Dinarello CA (1991a) Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 266:14147-14150.
21. Granowitz EV, Clark BD, Vannier E, Callahan MV, Dinarello CA (1991b) Interleukin-1 receptor antagonist inhibits interleukin-1 induced cytokine synthesis by human monocytes. Clin Res 39:462A.
22. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340.
23. Ikejima T, Zhang X, Wen, Dinarello CA (1991) IL-1 receptor antagonist (IL-1ra) reduces IL-1-mediated fever in the rabbit but not LPS or staphylococcus epidermidis-induced fever. Clin Res 39:462A.
24. Kent S, Bluthé RM, Dantzer R, Hardwick AJ, Kelley KW, Rothwell NJ, Vannice JL (1992) Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin-1. Proc Natl Acad Sci 89:9117-9120.
25. Kent S, Bret-Dibat JL, Kelley KW, Dantzer R (1996) Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci Biobehav Rev 20:171-175.
26. Krueger JM, Obal, F Jr, Opp M, Toth L, Johannsen L, Cady AB (1990) Somnogenic cytokines and models concerning their effects on sleep. Yale J Biol Med 63:157-172.
27. Layé S, Bluthé RM, Kent S, Combe C, Medina C, Parnet P, Kelley KW, Dantzer R (1995) Subdiaphragmatic vagotomy blocks the induction of interleukin-1β mRNA in the brain of mice in response to peripherally administered lipopolysaccharide. Am J Physiol (Regul Integrative Comp Physiol) 268:R1327-R1331.
28. Layé S, Parnet P, Goujon E, Dantzer R (1994) Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Molec Brain Res 27:157-162.
29. Lehmann AG (1974) Atlas Stéréotaxique du Cerveau de la Souris, Centre National de la Recherche Scientifique, Paris.
30. Luheshi G, Hopkins SJ, Lefeuvre RA, Dascombe MJ, Ghiara P, Rothwell N (1993) Importance of brain IL-1 type II receptors in fever and thermogenesis in the rat. Am J Physiol (Endocrinol Metab) 265:E585-E591.
31. McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, Kilian PL (1991) Inhibition of interleukin-1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 173:931-939.
32. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI, Copeland NG, Huebner K, Croce CM, Cannizzarro LA, Benjamin D, Dower SK, Spriggs MK, Sims JE (1991) A novel IL-1 receptor cloned from B cells by mammalian expression, is expressed in many cell types. Eur Molec Biol Org J 10:2821-2832.
33. Maier SF, Watkins LR (1995) Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res 695:279-282.
34. Mengozzi M, Bertini R, Sironi M, Ghezzi P (1991) Inhibition by inierleukin-1 receptor antagonist of in vivo activities of interleukin-1 in mice. Lymphokine Cytokine Res 10:405-407.
35. Obal F Jr, Opp M, Cady AB, Johannsen L, Postlethwaite AE, Poppleton HM, Seyer JM, Krueger JM (1990) Interleukin-1α and an interleukin-1β fragment are somnogenic. Am J Physiol (Regul Integr Comp Physiol) 259:R439-R446.
36. Opp MR, Krueger JM (1991) Interleukin-1 receptor antagonist blocks interleukin-1 induced sleep and fever. Am J Physiol (Regul Integr Comp Physiol) 260:R453-R457.
37. Parnet P, Amidari S, Wu C, Brunke-Reese D, Goujon E, Weyhenmeyer JA, Dantzer R, Kelley KW (1994) Expression of type I and type II interleukin-1 receptors in mouse brain. Molec Brain Res 27:63-70.
38. Parnet P, Brunke D, Goujon E, Demotes-Mainard J, Biragyn A, Arkins S, Mohler KM, Sims JE, Dantzer R, Kelley KW (1993) Molecular identification of two types of IL-1 receptors in the murine pituitary gland. J Neuroendocrinol 5:213-219.
39. Plata-Salaman CR, Ffrench-Mullen JMH (1992) Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-1β. Physiol Behav 51:1277-1279.
40. Pruitt JH, Copeland EM III, Moldawer LL (1995) Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 3:235-251.
41. Seckinger P, Dayer JM (1987) Interleukin-1 inhibitors. Ann Inst Pasteur/Immunol 138:461-516.
42. Sims JE, Acres B, Grubin CE, McMahan CJ, Wignall JM, March CJ, Dower SK (1989) Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci 86:8946-8950.
43. Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, McMahan CJ, Grubin CE, Wignall JM, Jackson JL, Call SM, Friend D, Alpert AR, Gillis S, Urdal DL, Dower SK. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241:585-589.
44. Spadaro F, Dunn AJ (1990) Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain Behav Immun 4:308-322.
45. Vogel SN, Henricson BE, Neta R (1991) Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia. Infect Immun 59:2494-2498.
46. Watkins LR, Goehler LE, Relton JK, Tartaglia N, Silbert L, Martin D, Maier SF (1995) Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 183:27-31.